Kaohsiung Show Chwan Memorial Hospital (KSCH) is set to install ZAP Surgical Systems’ ZAP-X Gyroscopic Radiosurgery platform, representing a major step forward in Taiwan’s neuro-oncology landscape.
The installation, scheduled for the fourth quarter of 2025, will begin treating patients from the first quarter of 2026.
Go deeper with GlobalData
Part of the Show Chwan Healthcare System, KSCH is a new medical facility in Taiwan.
The hospital is enhancing its neuro-oncology practice with the ZAP-X system, which offers non-invasive treatment for patients with brain tumours and other neurological disorders.
SRS is a non-invasive, painless procedure that treats brain tumours and other head and neck disorders without incisions.
Typically completed in a single outpatient visit, SRS represents a significant departure from traditional open surgery.
Show Chwan Healthcare System president Dr. Min-Ho Huang said: “SRS is revolutionising the way we treat brain tumours and neurological conditions.
“With the addition of ZAP-X at KSCH, we are reinforcing our commitment to providing world-class, non-invasive treatment solutions to patients in Taiwan and beyond.”
The integration of ZAP-X makes radiosurgery more accessible, removing the requirements for expensive shielded radiation rooms.
The ZAP-X platform uses a modern linear accelerator for radiation generation, avoiding the challenges of managing and replacing Cobalt-60 radioactive isotopes.
The gyroscopic design of the ZAP-X system allows for the precise targeting of tumours from thousands of angles, which helps to protect critical structures, such as the brain stem and optic nerves.
This precision reduces radiation exposure to healthy brain tissue, improving patient safety and preserving cognitive function.
The Show Chwan Healthcare System has traditionally used Cobalt-60 technology for SRS treatments.
The addition of the ZAP-X platform offers an alternative, promising to improve treatment versatility and accuracy.
